{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:43:16Z","timestamp":1789792996307,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009874","name":"Universit\u00e9 de Sherbrooke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.aca.2026.345450","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:25:14Z","timestamp":1774682714000},"page":"345450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and validation of a UHPLC\u2013MS\/MS method for the quantification of total conjugated 3-bromotyrosine and investigation of its association with asthma severity"],"prefix":"10.1016","volume":"1404","author":[{"given":"Mohamed","family":"Gamrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2360-5232","authenticated-orcid":false,"given":"Asma","family":"Farjallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3986-8571","authenticated-orcid":false,"given":"Floresse Merveilles","family":"Kpaossou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Cliche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-4513","authenticated-orcid":false,"given":"Carlos","family":"Celis-Preciado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7138-4518","authenticated-orcid":false,"given":"Morgane","family":"Gronnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Couillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Auray-Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2026.345450_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/alr.21609","article-title":"Asthma: definitions and pathophysiology","volume":"5","author":"Mims","year":"2015","journal-title":"Int. Forum Allergy Rhinol."},{"key":"10.1016\/j.aca.2026.345450_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.aca.2026.345450_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.aca.2026.345450_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","volume":"13","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.aca.2026.345450_bib5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1183\/23120541.00570-2021","article-title":"Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford asthma attack Risk Scale (ORACLE)","volume":"8","author":"Couillard","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.aca.2026.345450_bib6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI10072","article-title":"Eosinophil-dependent bromination in the pathogenesis of asthma","volume":"105","author":"Heinecke","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.aca.2026.345450_bib7","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1021\/bi982401l","article-title":"3-Bromotyrosine and 3,5-Dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo","volume":"38","author":"Wu","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.aca.2026.345450_bib8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1172\/JCI9702","article-title":"Eosinophils generate brominating oxidants in allergen-induced asthma","volume":"105","author":"Wu","year":"2000","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.aca.2026.345450_bib9","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.4049\/jimmunol.166.9.5763","article-title":"Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen Species1","volume":"166","author":"MacPherson","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.aca.2026.345450_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpeds.2011.01.029","article-title":"Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children","volume":"159","author":"Wedes","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.aca.2026.345450_bib11","doi-asserted-by":"crossref","first-page":"L548","DOI":"10.1152\/ajplung.00141.2022","article-title":"Urinary total conjugated 3-bromotyrosine, asthma severity, and exacerbation risk","volume":"323","author":"Wang","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.aca.2026.345450_bib12","article-title":"Recent insights in the role of biomarkers in severe asthma management","volume":"9\u20132022","author":"Fouka","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.aca.2026.345450_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/JAA.S496630","article-title":"Asthma biologics across the T2 spectrum of inflammation in severe asthma: biomarkers and mechanism of action","volume":"18","author":"Lindsley","year":"2025","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.aca.2026.345450_bib14","article-title":"Critical evaluation of asthma biomarkers in clinical practice","volume":"9\u20132022","author":"Guida","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.aca.2026.345450_bib15","article-title":"Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma","volume":"15\u20132024","author":"Porsbjerg","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345450_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2023-001932","article-title":"Phenotyping the responses to systemic corticosteroids in the management of asthma attacks (PRISMA): protocol for an observational and translational pilot study","volume":"10","author":"Celis-Preciado","year":"2023","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.aca.2026.345450_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02391-2024","article-title":"Phenotyping the responses to systemic corticosteroids in the management of asthma attacks (PRISMA)","volume":"65","author":"Celis-Preciado","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.aca.2026.345450_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2025-003750","article-title":"Integrating blood eosinophils and exhaled nitric oxide (FeNO) in asthma diagnostic pathways for adults and children: the PROPULSION SANT\u00c9 observational study with ranslational sub-studies (DIVE, DIVE2)","volume":"12","author":"Gronnier","year":"2025","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.aca.2026.345450_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.aca.2016.06.054","article-title":"UPLC-MS\/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses","volume":"936","author":"Auray-Blais","year":"2016","journal-title":"Anal. Chim. Acta"},{"issue":"6","key":"10.1016\/j.aca.2026.345450_bib20","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/ac203433e","article-title":"Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics","volume":"84","author":"Auray-Blais","year":"2012","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.aca.2026.345450_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4155\/bio-2022-0007","article-title":"Methylmalonic acid analysis using urine filter paper samples to screen for metabolic vitamin B12 deficiency in older adults","volume":"14","author":"Boutin","year":"2022","journal-title":"Bioanalysis"},{"issue":"3","key":"10.1016\/j.aca.2026.345450_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4155\/bio.15.239","article-title":"Evaluation of urinary Keratan sulfate disaccharides in mps iva patients using UPLC\u2013MS\/MS","volume":"8","author":"Auray-Blais","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.aca.2026.345450_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cca.2014.08.002","article-title":"Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry","volume":"438","author":"Auray-Blais","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.aca.2026.345450_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/diagnostics9040195","article-title":"Neonatal mass urine screening approach for early detection of mucopolysaccharidoses by UPLC-MS\/MS","volume":"9","author":"Menkovic","year":"2019","journal-title":"Diagnostics"},{"issue":"6","key":"10.1016\/j.aca.2026.345450_bib25","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/diagnostics12061414","article-title":"Quantitation of a urinary profile of biomarkers in gaucher disease type 1 patients using Tandem Mass spectrometry","volume":"12","author":"Menkovic","year":"2022","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.aca.2026.345450_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijns7010018","article-title":"Neonatal Urine Screening Program in the Province of Quebec: technological upgrade from thin layer chromatography to tandem mass spectrometry","volume":"7","author":"Auray-Blais","year":"2021","journal-title":"Int J Neonatal Screen."},{"issue":"19","key":"10.1016\/j.aca.2026.345450_bib27","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.2174\/092986712800784739","article-title":"Novel gb(3) isoforms detected in urine of fabry disease patients: a metabolomic study","volume":"19","author":"Auray-Blais","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.aca.2026.345450_bib28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ymgme.2009.04.009","article-title":"Fabry disease urinary globotriaosylceramide\/creatinine biomarker evaluation by liquid chromatography-tandem mass spectrometry in healthy infants from birth to 6 months","volume":"97","author":"Barr","year":"2009","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.aca.2026.345450_bib29","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/ac303033v","article-title":"Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry","volume":"85","author":"Lavoie","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2026.345450_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.20517\/rdodj.2024.14","article-title":"Longitudinal biomarker evaluation in Fabry disease patients receiving lentivirus-mediated gene therapy","volume":"3","author":"Auray-Blais","year":"2024","journal-title":"Rare Dis Orphan Drugs J"},{"issue":"1","key":"10.1016\/j.aca.2026.345450_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.11622\/smedj.2015003","article-title":"Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why","volume":"56","author":"Tang","year":"2015","journal-title":"Singapore Med J"},{"key":"10.1016\/j.aca.2026.345450_bib32","series-title":"Bioanalytical Method Validation: Guidance for Industry","year":"2018"},{"key":"10.1016\/j.aca.2026.345450_bib33","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s00216-011-4919-1","article-title":"Fingerprinting of egg and oil binders in painted artworks by matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of lipid oxidation by-products","volume":"400","author":"Calvano","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"issue":"24","key":"10.1016\/j.aca.2026.345450_bib34","doi-asserted-by":"crossref","first-page":"13382","DOI":"10.1021\/acs.analchem.7b03609","article-title":"Separation and analysis of lactosylceramide, galabiosylceramide, and globotriaosylceramide by LC-MS\/MS in urine of fabry disease patients","volume":"89","author":"Boutin","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2026.345450_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cca.2019.03.1615","article-title":"Tandem mass spectrometry analysis of urinary podocalyxin and podocin in the investigation of podocyturia in women with preeclampsia and Fabry disease patients","volume":"495","author":"Martineau","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"38","key":"10.1016\/j.aca.2026.345450_bib36","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1039\/D4AY00697F","article-title":"An LC-MS\/MS method for the quantification of 3-bromotyrosine in plasma from patients diagnosed with eosinophilic esophagitis","volume":"16","author":"Thomas","year":"2024","journal-title":"Anal. Methods"},{"issue":"21","key":"10.1016\/j.aca.2026.345450_bib37","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.3390\/molecules25215158","article-title":"Simultaneous LC-MS\/MS-Based quantification of free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in plasma of colorectal cancer patients during early postoperative period","volume":"25","author":"Fleszar","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.aca.2026.345450_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000195","article-title":"Corticosteroids for preventing relapse following acute exacerbations of asthma","author":"Rowe","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.aca.2026.345450_bib39","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.155.5.9154849","article-title":"Sputum inflammatory indices after prednisone treatment in severe asthma exacerbations","volume":"155","author":"Pizzichini","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.aca.2026.345450_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-2600(24)00299-6","article-title":"Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA)","volume":"13","author":"Ramakrishnan","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.aca.2026.345450_bib41","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1164\/ajrccm.161.5.9903102","article-title":"Asthma: from bronchoconstriction to airways inflammation and remodeling","volume":"161","author":"Bousquet","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl 1","key":"10.1016\/j.aca.2026.345450_bib42","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1513\/AnnalsATS.201506-385MG","article-title":"New insights in oxidant biology in asthma","volume":"13","author":"Erzurum","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.aca.2026.345450_bib43","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jaip.2023.02.042","article-title":"Clinically accessible biomarkers to assess the modifiable risk of asthma\/wheezing attacks in toddlers","volume":"11","author":"Couillard","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.aca.2026.345450_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1183\/23120541.00577-2024","article-title":"The carbon footprint of diagnostic delays in asthma","volume":"11","author":"Pouliot","year":"2025","journal-title":"ERJ Open Res"}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026004009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026004009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:06:06Z","timestamp":1778961966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267026004009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0003267026004009"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2026.345450","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a UHPLC\u2013MS\/MS method for the quantification of total conjugated 3-bromotyrosine and investigation of its association with asthma severity","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2026.345450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"345450"}}